Regenerative medicine is a broad term for treatments intended to help the body repair or manage damaged tissue, including options such as platelet-rich plasma (PRP) and products marketed as stem cell therapies. These approaches are an area of active research and growing interest for certain types of joint, tendon, and spine-related pain. However, the evidence and regulatory status of these treatments vary significantly depending on the specific product and technique used, and patients should clearly understand these differences before considering treatment. At the Center for Spine & Pain Medicine (CSPM), an individual evaluation helps determine whether any regenerative option is reasonable to discuss as part of a broader pain-management plan.
Regenerative Medicine and Stem Cell Injections
What Is Regenerative Medicine?
Regenerative medicine refers to a category of treatments intended to support the body's own tissue repair processes, most commonly through injections such as platelet-rich plasma (PRP) or products marketed as containing stem cells, in an effort to help manage certain types of joint, tendon, or spine-related pain.
This is a broad and evolving field, and the specific products and techniques used can vary widely between practices. Platelet-rich plasma is prepared from a small sample of a patient's own blood, which is processed to concentrate platelets before being injected into or near an area of injury or degeneration. Other products marketed under the regenerative medicine label may be derived from a patient's own bone marrow or fat tissue, or from donated birth tissue such as umbilical cord or amniotic fluid. These different product types are not interchangeable, are regulated differently, and have varying levels of supporting evidence, as discussed in more detail below.
Important FDA Information About Stem Cell and Regenerative Medicine Products
Patients should know that, according to the U.S. Food and Drug Administration (FDA), stem cell products generally require FDA approval, and the only stem cell products currently approved in the United States are blood-forming stem cells derived from umbilical cord blood, used for disorders affecting blood production. The FDA has stated directly that no regenerative medicine product, including stem cell and exosome products, has been approved for the treatment of any orthopedic condition such as osteoarthritis, tendonitis, disc disease, back pain, hip pain, knee pain, neck pain, or shoulder pain.
Products marketed as containing amniotic or umbilical cord stem cells are a particular area of FDA concern, as the agency has noted that many such products do not contain viable stem cells despite their marketing. Platelet-rich plasma (PRP) is regulated differently from stem cell products because it is generally prepared from a patient's own blood with minimal processing. However, PRP is not FDA-approved as a treatment for any specific condition; rather, it is used by physicians as part of individualized patient care. Patients considering any regenerative medicine product should ask their provider directly what the product is, how it is regulated, and what evidence supports its use for their specific condition.
What Conditions May Regenerative Medicine Address?
Regenerative medicine techniques, particularly PRP, have been studied most for joint conditions such as knee osteoarthritis and certain tendon injuries, and are also used by some practices for spine-related conditions, though the strength of supporting evidence varies by condition and by the specific product used.
Because this field is evolving quickly and includes a wide range of products and techniques, patients should ask CSPM directly which conditions its regenerative medicine program addresses and what specific products or techniques are used. For a broader look at the conditions CSPM evaluates, visit CSPM's conditions page.
Who May Be a Candidate for Regenerative Medicine?
A person may be a candidate for a regenerative medicine consultation if they have a joint, tendon, or spine-related condition that has not fully responded to conservative treatment, and are interested in exploring additional options, though candidacy for any specific product or technique must be confirmed individually by a physician.
Because evidence and regulatory status vary widely across this treatment category, physicians typically discuss a patient's diagnosis, prior treatments, expectations, and overall health before determining whether any specific regenerative option is reasonable to consider. Patients should expect a thorough, honest conversation about what is and is not currently supported by strong evidence for their specific condition.
Who May Not Be a Candidate for Regenerative Medicine?
Certain patients may not be appropriate candidates, including those with active infection near the treatment site, certain bleeding or blood disorders, or an underlying condition that a physician determines makes injection-based treatment inadvisable. This is not a complete list, and candidacy should always be confirmed directly with a physician.
What Happens Before the Procedure?
Before any regenerative medicine procedure, a patient typically has a consultation in which the physician reviews the diagnosis, imaging, and prior treatment history, and discusses which specific product or technique, if any, may be reasonable to consider. Patients should ask directly about the source and regulatory status of any proposed product. Specific preparation instructions should come directly from CSPM based on the individual treatment plan.
What Happens During the Procedure?
In general, PRP preparation involves drawing a small sample of the patient's blood, processing it to concentrate platelets, and then injecting the resulting solution into or near the target area, often using imaging guidance for accuracy. Patients should ask CSPM directly what their specific procedure involves.
Does Regenerative Medicine Hurt?
Most patients feel pressure or mild discomfort from the injection rather than significant pain, though sensitivity varies from person to person. The initial blood draw for PRP involves a brief needle stick similar to routine bloodwork.
Local anesthetic may be used at the injection site depending on the technique. Some patients notice temporary soreness or swelling at the injection site afterward, which is a normal part of the tissue response some of these treatments are intended to stimulate. Any severe or worsening pain should be reported to the treating physician promptly.
How Long Does the Procedure Take?
Patients should ask CSPM directly for the expected appointment duration, as it can vary depending on the specific product used and whether blood or tissue needs to be processed on-site.
How Long Is Recovery After Regenerative Medicine Injections?
Recovery expectations vary by technique and area treated, and patients should confirm activity restrictions directly with their physician.
Because some regenerative techniques are intended to trigger an initial inflammatory or healing response, mild soreness or swelling for several days afterward is common and does not necessarily indicate a problem. Physicians may recommend a period of modified activity or specific rehabilitation exercises afterward. These general points should not replace individualized instructions provided by the treating physician.
When Might a Patient Notice Results?
Any changes in symptoms are typically assessed over weeks to months, not immediately, since these treatments are intended to support a gradual tissue-healing process rather than provide immediate pain relief. Published research on PRP for knee osteoarthritis has generally assessed outcomes at six-month intervals or longer, rather than in the days immediately following treatment.
How Long Might the Results Last?
The duration of any benefit varies by individual, condition, and the specific product used. A 2025 systematic review and meta-analysis of PRP for knee osteoarthritis reported statistically significant improvements in pain and function scores at 6 and 12 months compared with baseline, whereas other systematic reviews of PRP for the same condition have reported more modest or inconsistent effects. These findings describe outcomes across groups of study participants in specific research settings and do not predict how any one patient will respond.
How Much Does Regenerative Medicine Cost?
Regenerative medicine procedures are frequently not covered by insurance and are often paid for out of pocket, so an accurate cost estimate requires reviewing pricing directly with CSPM's billing team before scheduling.
Cost can vary widely depending on the specific product used, the area treated, and whether multiple treatment sessions are recommended. Patients can review general billing information on CSPM's financial policy page and should ask directly what is included in any quoted price.
Does Insurance Cover Regenerative Medicine?
Many insurance plans, including Medicare, do not cover PRP or stem cell-related injections for orthopedic or spinal conditions because these treatments are generally considered investigational or not medically necessary under current policy definitions. Patients should confirm coverage directly with their insurance plan rather than assume it is included.
Patients considering these treatments should ask both their insurance plan and CSPM directly whether any portion of the cost may be covered, and should be cautious of any provider who guarantees coverage or reimbursement in advance. Patients can find general billing information on CSPM's financial policy page.
What Is the Success Rate of Regenerative Medicine?
There is no single success rate for "regenerative medicine" as a category because it encompasses a wide range of products with varying levels of supporting evidence, and reported outcomes vary by condition, product, and study design.
For PRP specifically, a 2025 systematic review and meta-analysis of six randomized controlled trials in patients with mild-to-moderate knee osteoarthritis found statistically significant improvements in standardized pain and function scores at 6 and 12 months compared with baseline. However, other systematic reviews of PRP for knee osteoarthritis have reported more modest or inconsistent benefits, and researchers have noted that the clinical significance of these effects is still debated. For stem cell and other regenerative products, the FDA has stated that none of these products are approved for orthopedic conditions, and rigorous, large-scale evidence supporting routine use for pain conditions is limited. Patients should ask directly what evidence exists for the specific product being proposed for their specific condition.
What Are the Risks and Side Effects?
As with any injection-based procedure, there are possible risks and side effects, and patients should discuss these in detail with their physician, particularly given the variability in products used across this field.
Commonly reported effects can include temporary pain, swelling, or bruising at the injection site. Less common risks include infection or an allergic reaction. The FDA has specifically warned about serious adverse events, including infections, associated with some unapproved regenerative medicine products, particularly those involving donor tissue rather than a patient's own blood or bone marrow. Patients should ask directly about the source and processing of any product used and should promptly report any concerning symptoms to their physician.
What Are the Alternatives to Regenerative Medicine?
Alternatives may include physical therapy, activity modification, oral or topical medication management, corticosteroid or other injections, or, depending on the condition, other interventional procedures, and no single option is automatically the right choice for every patient.
Depending on the individual case, a physician may also discuss more established options such as epidural steroid injections or facet joint injections for spine-related pain, or a referral to an orthopedic specialist for certain joint conditions.
How Do Platelet-Rich Plasma and Stem Cell-Marketed Products Compare?
| Feature | Platelet-Rich Plasma (PRP) | Products marketed as "stem cell" therapy |
|---|---|---|
| Source | Patient's own blood | Varies: patient's own bone marrow/fat, or donor birth tissue (umbilical cord, amniotic fluid) |
| FDA approval status | Not FDA-approved for a specific condition; used as part of individualized care | FDA has not approved any such product for orthopedic conditions |
| Level of processing | Minimal (centrifugation to concentrate platelets) | Varies; donor-tissue products are a particular area of FDA scrutiny |
| Supporting evidence | Multiple randomized controlled trials, particularly for knee osteoarthritis, with mixed-to-modest results | Limited large-scale evidence for orthopedic or pain conditions |
| Typical insurance coverage | Rarely covered | Rarely covered |
This table offers a general comparison only and does not describe any specific product CSPM may or may not use. Patients should ask directly which category a proposed treatment falls into and request the supporting evidence for that specific product.
When Should Someone Discuss Regenerative Medicine With a Pain Specialist?
Someone with a chronic joint-, tendon-, or spine-related condition who is curious about regenerative medicine options may want to ask a pain specialist for an honest assessment of the evidence supporting these treatments for their specific condition. A pain specialist can review a patient's diagnosis and treatment history and help them understand which options, if any, are reasonable to consider alongside more established treatments. To Schedule a consultation with CSPM, visit the appointment page.
Frequently Asked Questions
Is regenerative medicine the same as stem cell therapy?
No, "regenerative medicine" is a broad umbrella term that includes several different types of treatments, including PRP and various products marketed as containing stem cells. These products differ significantly in how they are made, how they are regulated, and what evidence supports their use. A patient considering any regenerative treatment should ask specifically which type of product is being proposed rather than assuming all regenerative treatments are the same.
Has the FDA approved stem cell injections for back or joint pain?
No. The FDA has stated directly that no regenerative medicine product, including stem cell products, has been approved for the treatment of any orthopedic condition, including back pain, neck pain, knee pain, hip pain, tendonitis, or disc disease. The only FDA-approved stem cell products currently available in the United States are used to treat disorders affecting blood production, not orthopedic or pain conditions. Patients considering any stem cell product for pain should ask their provider directly about its regulatory status.
Is PRP the same thing as a stem cell injection?
No. PRP is prepared from a patient's own blood and is regulated differently than products marketed as stem cell therapies, since PRP generally involves minimal processing of the patient's own tissue. PRP is not FDA-approved as a treatment for any specific condition, but it has been studied in several randomized clinical trials, particularly for knee osteoarthritis. Patients should not assume PRP and stem cell products carry the same evidence or regulatory status.
Why isn't regenerative medicine typically covered by insurance?
Many insurance plans, including Medicare, classify PRP and stem cell-related treatments for orthopedic and spine conditions as investigational or not medically necessary under current coverage policies, which generally means the cost is not reimbursed. Coverage policies can change over time and vary by plan, so patients should confirm their specific benefits directly with their insurance provider. Patients should be cautious of any clinic that guarantees insurance coverage or reimbursement for these treatments in advance.
How do I know if a regenerative medicine product being offered to me is legitimate?
The FDA recommends asking your provider directly what the product is, whether it requires FDA approval, and whether it has that approval, since there is a lot of misleading marketing information about these products. Patients can also contact the FDA directly with questions about a specific product's regulatory status. Being cautious of any provider who guarantees a cure, discourages questions, or cannot clearly explain what is in the product being used is a reasonable and protective step.
Are there serious risks associated with unapproved regenerative medicine products?
Yes, the FDA has issued warnings about serious adverse events, including infections, linked to some unapproved regenerative medicine products, particularly those involving donor tissue processed outside of FDA oversight. This is one of the reasons the FDA encourages patients to ask detailed questions about any regenerative product before treatment and to report any adverse events they experience. A qualified physician can help patients weigh these risks against any potential benefit for their specific situation.
Medical Review
Reviewed by Dr. Sadiq, MD.
Sources
- Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes – U.S. Food and Drug Administration, 2024.
- Efficacy of Platelet-Rich Plasma Injections in Knee Osteoarthritis: A Systematic Review and Meta-Analysis – Cureus, 2025.
- Efficacy of intra-articular platelet-rich plasma compared with placebo in knee osteoarthritis: A systematic review and meta-analysis – ScienceDirect (Osteoarthritis and Cartilage-affiliated journal), 2025.